| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 04/22/2021 | IMPEL PHARMACEUTICALS INC | IMPL | Other (acquisition) | 5% Convertible Note due 2021 | 0 | $0.00 | $0 | See footnote | 04/22/2021 |
| 04/22/2021 | IMPEL PHARMACEUTICALS INC | IMPL | Other (acquisition) | 5% Convertible Note due 2021 | 0 | $0.00 | $0 | See footnote | 04/22/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Common Stock | 944.1k | $0.00 | $0 | By Vivo PANDA Fund, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Common Stock | 472.3k | $0.00 | $0 | By Vivo PANDA Fund, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Sale | Common Stock | 62 | $20.00 | $1.2k | By Vivo PANDA Fund, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Common Stock | 1.1M | $0.00 | $0 | By Vivo Capital Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Common Stock | 317.9k | $0.00 | $0 | By Vivo Capital Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Common Stock | 345.6k | $0.00 | $0 | By Vivo Capital Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Sale | Common Stock | 144 | $20.00 | $2.9k | By Vivo Capital Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Purchase | Common Stock | 175.7k | $20.00 | $3.5M | By Vivo Capital Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Common Stock | 150.8k | $0.00 | $0 | By Vivo Capital Surplus Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Common Stock | 43.9k | $0.00 | $0 | By Vivo Capital Surplus Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Common Stock | 47.7k | $0.00 | $0 | By Vivo Capital Surplus Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Sale | Common Stock | 20 | $20.00 | $400 | By Vivo Capital Surplus Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Purchase | Common Stock | 24.3k | $20.00 | $485.3k | By Vivo Capital Surplus Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Purchase | Common Stock | 150k | $20.00 | $3M | By Vivo Opportunity Fund, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Series A-1 Preferred Stock | 944.1k | $0.00 | $0 | By Vivo PANDA Fund, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Series B Preferred Stock | 472.3k | $0.00 | $0 | By Vivo PANDA Fund, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Exercise (in-the-money or at-the-money) | Warrant (Right to Buy) | 17.7k | $0.07 | $1.2k | By Vivo PANDA Fund, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Series B Preferred Stock | 1.1M | $0.00 | $0 | By Vivo Capital Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Series C-1 Preferred Stock | 317.9k | $0.00 | $0 | By Vivo Capital Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Series C-2 Preferred Stock | 345.6k | $0.00 | $0 | By Vivo Capital Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Exercise (in-the-money or at-the-money) | Warrant (Right to Buy) | 41k | $0.07 | $2.9k | By Vivo Capital Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Series B Preferred Stock | 150.8k | $0.00 | $0 | By Vivo Capital Surplus Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Series C-1 Preferred Stock | 43.9k | $0.00 | $0 | By Vivo Capital Surplus Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Conversion | Series C-2 Preferred Stock | 47.7k | $0.00 | $0 | By Vivo Capital Surplus Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Bolt Biotherapeutics, Inc. | BOLT | Exercise (in-the-money or at-the-money) | Warrant (Right to Buy) | 5.7k | $0.07 | $395.8 | By Vivo Capital Surplus Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Terns Pharmaceuticals, Inc. | | Conversion | Common Stock | 1.9M | $0.00 | $0 | Vivo Capital Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Terns Pharmaceuticals, Inc. | | Conversion | Common Stock | 266.9k | $0.00 | $0 | Vivo Capital Surplus Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Terns Pharmaceuticals, Inc. | | Purchase | Common Stock | 103.4k | $17.00 | $1.8M | Vivo Capital Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Terns Pharmaceuticals, Inc. | | Purchase | Common Stock | 14.3k | $17.00 | $242.7k | Vivo Capital Surplus Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Terns Pharmaceuticals, Inc. | | Purchase | Common Stock | 357.4k | $17.00 | $6.1M | Vivo Opportunity Fund, L.P. | 02/09/2021 |
| 02/09/2021 | Terns Pharmaceuticals, Inc. | | Conversion | Series B Preferred Stock | 713.2k | $0.00 | $0 | Vivo Capital Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Terns Pharmaceuticals, Inc. | | Conversion | Series B Preferred Stock | 98.5k | $0.00 | $0 | Vivo Capital Surplus Fund VIII, L.P. | 02/09/2021 |
| 02/09/2021 | Terns Pharmaceuticals, Inc. | | Conversion | Series C Preferred Stock | 364.1k | $0.00 | $0 | Vivo Capital Fund VIII, L.P. | 02/09/2021 |
|